Viracta Therapeutics Pink Sheet Forecast - 8 Period Moving Average
| VIRXDelisted Stock | USD 0.03 0 7.38% |
The 8 Period Moving Average forecasted value of Viracta Therapeutics on the next trading day is expected to be 0.10 with a mean absolute deviation of 0.02 and the sum of the absolute errors of 1.25. Viracta Pink Sheet Forecast is based on your current time horizon.
Viracta |
Viracta Therapeutics 8 Period Moving Average Price Forecast For the 24th of March
Given 90 days horizon, the 8 Period Moving Average forecasted value of Viracta Therapeutics on the next trading day is expected to be 0.10 with a mean absolute deviation of 0.02, mean absolute percentage error of 0, and the sum of the absolute errors of 1.25.Please note that although there have been many attempts to predict Viracta Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Viracta Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Viracta Therapeutics Pink Sheet Forecast Pattern
| Backtest Viracta Therapeutics | Viracta Therapeutics Price Prediction | Buy or Sell Advice |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the 8 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Viracta Therapeutics pink sheet data series using in forecasting. Note that when a statistical model is used to represent Viracta Therapeutics pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 96.6788 |
| Bias | Arithmetic mean of the errors | 0.0076 |
| MAD | Mean absolute deviation | 0.0236 |
| MAPE | Mean absolute percentage error | 0.2939 |
| SAE | Sum of the absolute errors | 1.2485 |
Predictive Modules for Viracta Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Viracta Therapeutics. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.View Viracta Therapeutics Related Equities
| Risk & Return | Correlation |
Viracta Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Viracta Therapeutics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Viracta Therapeutics shares will generate the highest return on investment. By undertsting and applying Viracta Therapeutics pink sheet market strength indicators, traders can identify Viracta Therapeutics entry and exit signals to maximize returns.
Viracta Therapeutics Risk Indicators
The analysis of Viracta Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Viracta Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting viracta pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 10.18 | |||
| Standard Deviation | 15.98 | |||
| Variance | 255.47 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in Viracta Pink Sheet
If you are still planning to invest in Viracta Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Viracta Therapeutics' history and understand the potential risks before investing.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |